Christopher P. Lowe insider trades: Vincerx Pharma (VINC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 25, 2022 | VINC | ↑ Buy | 30,000 | $1.65 | $49K | Direct | Aug 26, 2022 (1d) |
| Oct 5, 2021 | CRTX | ↓ Sell | 4,963 | $98.50 | $489K | Direct | Oct 7, 2021 (2d) |
| Aug 16, 2021 | CRTX | ↓ Sell | 22,000 | $95.31 | $2.1M | Direct | Aug 18, 2021 (2d) |
| Jun 30, 2021 | VINC | ↑ Buy | 10,000 | $12.62 | $126K | Direct | Jun 30, 2021 (0d) |
| Jun 28, 2021 | CRTX | ↓ Sell | 20,000 | $54.15 | $1.1M | Direct | Jun 30, 2021 (2d) |
| May 20, 2014 | HNSN | ↑ Buy | 20,000 | $1.44 | $29K | Direct | May 20, 2014 (0d) |
| May 13, 2013 | HNSN | ↑ Buy | 12,500 | $1.52 | $19K | Direct | May 15, 2013 (2d) |
| Feb 1, 2012 | ANTH | ↓ Sell | 15,000 | $7.66 | $115K | Direct | Feb 3, 2012 (2d) |
| Nov 3, 2011 | ANTH | ↓ Sell10b5-1 | 15,000 | $6.88 | $103K | Direct | Nov 4, 2011 (1d) |
| Oct 25, 2011 | ANTH | ↓ Sell10b5-1 | 4,637 | $7.07 | $33K | By spouse | Oct 27, 2011 (2d) |
| Aug 3, 2011 | ANTH | ↓ Sell10b5-1 | 14,600 | $6.88 | $100K | Direct | Aug 4, 2011 (1d) |
| Aug 2, 2011 | ANTH | ↓ Sell10b5-1 | 5,000 | $7.31 | $37K | By spouse | Aug 4, 2011 (2d) |
| Sep 24, 2010 | ANTH | ↑ Buy | 5,000 | $4.18 | $21K | Direct | Sep 24, 2010 (0d) |
| Apr 30, 2010 | HNSN | ↑ Buy | 10,000 | $2.66 | $27K | Direct | Apr 30, 2010 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Christopher P. Lowe's insider trades
Christopher P. Lowe is a director at Vincerx Pharma (VINC). Since Apr 30, 2010, Christopher has reported 6 open-market purchases worth $271K and 8 sales worth $4.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
4 sales (7% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (26 filings), option exercises (8 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VINC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.